This company has been marked as potentially delisted and may not be actively trading.

Soleno Therapeutics (SLNO) Stock Forecast & Price Target

Get the Latest News and Ratings for SLNO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Soleno Therapeutics and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SLNO Analyst Ratings Over Time

Type	Current Forecast 6/15/25 to 6/15/26	1 Month Ago 5/16/25 to 5/16/26	3 Months Ago 3/17/25 to 3/17/26	1 Year Ago 6/15/24 to 6/15/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	12 Buy rating(s)	8 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	2 Sell rating(s)	2 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$76.67	$76.67	$106.85	$106.78
Forecasted Upside	44.63% Upside	44.63% Upside	217.81% Upside	34.91% Upside
Consensus Rating	Hold	Hold	Moderate Buy	Buy

SLNO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SLNO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Soleno Therapeutics Stock vs. The Competition

Type	Soleno Therapeutics	Medical Companies	Broader Market
Consensus Rating Score	2.08	2.29	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	44.63% Upside	695.35% Upside	13.95% Upside
News Sentiment Rating	Positive News See Recent SLNO News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/19/2026	Cantor Fitzgerald 5 of 5 stars	Kristen Kluska 5 of 5 stars	Reiterated Rating	Neutral
5/11/2026	Zacks Research Not Rated		Downgrade	Hold ➝ Strong Sell
4/17/2026	Wells Fargo & Company 3 of 5 stars	Derek Archila 4 of 5 stars	Set Target	Overweight ➝ Equal Weight	$110.00 ➝ $53.00	+0.82%
4/8/2026	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$100.00 ➝ $53.00	+1.24%
4/7/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
4/7/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Van Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$85.00 ➝ $53.00	+1.47%
4/7/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kalpit Patel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Outperform ➝ Hold
4/6/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
4/6/2026	Lifesci Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
3/18/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leland Gershell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$110.00 ➝ $80.00	+139.29%
Get the Latest News and Ratings for SLNO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Soleno Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
1/22/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Sell (D-)
10/7/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target	Buy	$125.00	+101.66%
8/27/2025	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Debjit Chattopadhyay Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$106.00	+51.94%
3/28/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Condulis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$74.00 ➝ $108.00	+52.89%
3/27/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$105.00	+42.53%
3/27/2025	Laidlaw Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yale Jen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$75.00 ➝ $105.00	+54.39%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 02:06 PM ET.

SLNO Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Soleno Therapeutics is $76.67, with a high forecast of $125.00 and a low forecast of $53.00.

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Soleno Therapeutics in the last twelve months. There are currently 2 sell ratings, 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SLNO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SLNO, but not buy additional shares or sell existing shares.

According to analysts, Soleno Therapeutics's stock has a predicted upside of 44.63% based on their 12-month stock forecasts.

Over the previous 90 days, Soleno Therapeutics's stock had 9 downgrades by analysts.

Soleno Therapeutics has been rated by research analysts at Cantor Fitzgerald, HC Wainwright, Lifesci Capital, Oppenheimer, Piper Sandler, Robert W. Baird, TD Cowen, Wells Fargo & Company, Wolfe Research, and Zacks Research in the past 90 days.

Analysts like Soleno Therapeutics less than other "medical" companies. The consensus rating score for Soleno Therapeutics is 2.08 while the average consensus rating score for "medical" companies is 2.29. Learn more on how SLNO compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Soleno Therapeutics Recommendations

This page (NASDAQ:SLNO) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.